In the non‐cancer cohort, 25/492 (5%) participants carried 17 unique P/LP variants in ATM, BRCA2, BRIP1, CHEK2, MUTYH, NBN, and PMS2 genes (Table S4). Here, CHEK2 is linked to cancer.